An interview with Elizabeth Douville, PhD, ICD.D, President and CEO of IRICoR, in Premières en affaires, where she shares her non-linear journey from research labs to becoming a key figure in advancing research in Canada.
🎯 She discusses the challenges women face in science and business, emphasizing the need for mentorship and collective efforts to improve diversity […]

IRICoR announces its participation in the BIO 2024 international convention to be held from June 3 to 6, 2024 in San Diego.
This industry event aims to create business opportunities among life science players from all over the world. It is also an opportunity for companies and institutions to develop partnerships of interest with complementary organizations, in particular through the presentation […]

 
The new issue of BIOTECanada’s Insights magazine is now available. IRICoR is proud to have once again collaborated on this new edition. Find an article highlighting how by embracing collaboration and investing appropriately in human capital, infrastructure and research we will catalyze the emergence of therapeutic solutions.
 
To read the full article, click here
 
To consult the […]

We are delighted to welcome the Government of Canada’s announcement of an investment of nearly $574 million in 19 projects, thanks to the Canada Biomedical Research Fund and the Biosciences Research Infrastructure Fund.
At IRICoR, we are particularly excited because we will have the privilege of contributing to the intellectual property strategy and commercial development of one of the selected projects. […]

“The life sciences infrastructure, both human and physical, that had painstakingly been built over the first few decades of the industry’s existence, has slowly but surely eroded such that Canada has now lost its place as a leader in life sciences and is struggling to keep up.”
 
An Op-eds article by Elizabeth Douville in TheFutureEconomy.ca
In this article, Dre. […]

 
 
Quebec innovation in the life sciences, supported by players such as IRICoR, plays a vital role in improving the quality of life of patients and makes a significant contribution to meeting the challenges facing the healthcare system.
Read about IRICoR in the special Research section of Le Devoir – BIS.
Among other things, the article highlights the importance of […]

 
On February 21, Elizabeth Douville, PhD, ICD.D, President and CEO of the organization, will be a panelist at the event “How can Quebec become a global leader in Life Science Innovation?”, organized by the Conseil des relations internationales de Montréal (CORIM).
This discussion between Gordon McCauley (adMare BioInnovations), Stefan Raos (Moderna), Lloyd Mitchell Segal (

 
IRICoR will attend the AUTM Annual Meeting, February 18-21, 2024.
AUTM’s Annual Meeting invites technology transfer professionals from around the globe to network, make deals and gain valuable insights from world-class speakers and panels.
If you would like to meet with IRICoR at AUTM 2024, please contact Jean-louis Brochu, M.Sc., Director Intellectual property and communication or Narjes Achach, Intellectually property Analyst, who […]

Narjes Achach, PharmD, LLM, Intellectual Property Analyst at IRICoR, took up pen to write a brilliant and insightful articleon the Equity, Diversity and Inclusion in the AUTM newsletter.
What can we do to keep the discussion open and move forward as a society and individual?
? 3 words : Educate / Engage / Endure
 
“In this column we often […]

IRICoR will attend the 29th  Annual International Partnering Conference BIO-Europe. This conference is being held from November 6 to November 8, 2023 in Munich, Germany.
This industry event aims to create business opportunities between life science players from around the world. It is also an opportunity for companies and institutions to develop partnerships of interest with complementary organizations, notably by presenting […]